A Randomized, Open-label Study to Compare the Platelet Inhibition With VerifyNow Assay of Ticagrelor Versus Clopidogrel in Troponin Negative Acute Coronary Syndrome Subjects Undergoing Ad Hoc Percutaneous Coronary Intervention
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Thrombosis
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 08 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Apr 2014 Planned number of patients changed from 100 to 120 as reported by ClinicalTrials.gov record.
- 28 Apr 2014 Planned End Date changed from 1 Oct 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov record.